Okay, let's tackle this question about the major source of estrogen in postmenopausal women. First, I need to recall what happens hormonally after menopause. Menopause means the ovaries stop functioning, so the main estrogen production there would cease. But wait, there must be another source. I remember that in postmenopausal women, estrogen is produced elsewhere in the body.

The core concept here is about the sources of estrogen after menopause. Normally, the ovaries produce estradiol, the primary estrogen. But once a woman is postmenopausal, the ovaries no longer produce significant amounts. So where does the estrogen come from then? I think it's from the conversion of androgens in other tissues. Specifically, aromatase converts androgens like androstenedione or testosterone into estrogens in peripheral tissues.

So the correct answer should be adipose tissue. Wait, but some might confuse this with the ovaries still producing some estrogen. No, after menopause, the ovaries are inactive. The adrenal glands do produce some androgens, but the main conversion happens in peripheral tissues. Adipose tissue has aromatase, which converts androgens to estrogens. So the major source is the conversion in fat tissue.

Looking at the options, if the correct answer is adipose tissue, then the other options might be the ovaries, adrenal glands, or testes. The ovaries are incorrect because they stop producing estrogen after menopause. The adrenal glands do produce some androgens, but the main conversion to estrogen happens elsewhere. The testes aren't a source in women. So the key here is understanding the role of peripheral aromatase in estrogen production post-menopause.

The clinical pearl here is that aromatase inhibitors are used in postmenopausal women with estrogen receptor-positive breast cancer because they block this peripheral conversion. That's a high-yield fact for exams. So the correct answer is adipose tissue via aromatase conversion of androgens.

**Core Concept**
Postmenopausal estrogen production shifts from ovarian follicles to peripheral tissues. The primary mechanism involves aromatase-mediated conversion of androgens to estrogens in extragonadal sites.

**Why the Correct Answer is Right**
In postmenopausal women, ovarian estrogen synthesis ceases. The major source becomes **adipose tissue**, where androstenedione (from adrenal and ovarian residual androgens) is aromatized to estrone (E1) by the enzyme **aromatase** (CYP19A1). Estrone is then peripherally converted to estradiol (E2) in tissues like the liver. This pathway accounts for ~80% of circulating estrogen in postmenopausal women.

**Why Each Wrong Option is Incorrect**
**Option A:** Ovaries are inactive postmenopause and no longer produce significant estrogen.
**Option B:** Adrenal glands secrete weak androgens (e.g., DHEA) but lack sufficient aromatase to be a primary estrogen source.
**Option C:** Testes are not present in women and are irrelevant to estrogen production.

**Clinical Pearl / High-Yield Fact**
Aromatase inhibitors (e.g., letrozole) are first-line for postmenopausal estrogen receptor-positive breast cancer, as they

✓ Correct Answer: A. Peripheral conversion of androstenedione